Reeve Emma's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Sep 16, 2025
- Accession no.
- 0001680329-25-000004
- Filed
- Sep 16, 2025
- Trade date
- Sep 11, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $934.4K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reeve EmmaCIK 0001680329 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | SSaleDisposed | −3,534 | $59.50 | −$210,273 | 11,666 | Direct | |
| Sep 11, 2025 | Common Stock | SSaleDisposed | −1,334 | $59.50 | −$79,373 | 10,332 | Direct | |
| Sep 11, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $25.69 | +$256,900 | 20,332 | Direct | |
| Sep 11, 2025 | Common Stock | SSaleDisposed | −10,000 | $59.50 | −$595,000 | 10,332 | Direct | |
| Sep 11, 2025 | Common Stock | MOption exerciseAcquired | +837 | $33.63 | +$28,148.31 | 11,169 | Direct | |
| Sep 11, 2025 | Common Stock | SSaleDisposed | −837 | $59.50 | −$49,801.5 | 10,332 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Sep 11, 2025 | Common Stock | MOption exerciseDisposed | −837 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.